STOCK TITAN

Cardinal Health shareholders elect 11 directors

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Cardinal Health, Inc. (CAH) reported that shareholders at its November 12, 2026 annual meeting elected 11 nominees to its Board of Directors: Robert W. Azelby, Michelle M. Brennan, Sheri H. Edison, David C. Evans, Patricia A. Hemingway Hall, Jason M. Hollar, Akhil Johri, Nancy Killefer, Christine A. Mundkur, Robert W. Musslewhite and Sudhakar Ramakrishna. Their terms run until the 2027 annual meeting and until successors are elected and qualified, or an earlier resignation, removal or death.

Shareholders approved named executive officer compensation on a non-binding advisory basis, with 173,487,665 votes for and 8,501,886 against. They also ratified Ernst & Young LLP as independent auditor for the fiscal year ending June 30, 2027.

Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Director nominees elected 11 nominees At the November 12, 2026 annual meeting
Say-on-pay votes for 173,487,665 votes Non-binding advisory vote on named executive officer compensation
Say-on-pay votes against 8,501,886 votes Non-binding advisory vote on named executive officer compensation
Auditor ratification votes for 189,914,603 votes Ratification of Ernst & Young LLP as independent auditor
Auditor ratification votes against 13,635,497 votes Ratification of Ernst & Young LLP as independent auditor
say-on-pay regulatory
"“say-on-pay” vote"
A say-on-pay is a shareholder vote that gives investors a chance to approve or disapprove a company’s executive compensation packages, typically held at annual meetings. It matters because the vote signals investor satisfaction with how leaders are paid—like customers rating how well managers are rewarded—and can push boards to change pay plans, reducing governance risk and affecting investor confidence and stock value even though the vote is usually advisory rather than legally binding.
broker non-votes technical
"Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were the results of CAH's 2026 annual meeting?

Shareholders elected 11 director nominees, approved named executive officer compensation on a non-binding advisory basis, and ratified Ernst & Young LLP as independent auditor for the fiscal year ending June 30, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0000721371false00007213712026-11-122026-11-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 12, 2026
 
Cardinal Health, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Ohio1-1137331-0958666
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
7000 Cardinal Place, Dublin, Ohio 43017
(Address of Principal Executive Offices) (Zip Code)
(614) 757-5000
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common shares (without par value)CAHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨




Item 5.07.    Submission of Matters to a Vote of Security Holders.

Cardinal Health, Inc. (the "Company") held its 2026 Annual Meeting of Shareholders (the "Annual Meeting") on November 12, 2026. See the Company’s definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on September 21, 2026 (the “Proxy Statement”) for more information on the three proposals included in the Proxy Statement for the Annual Meeting.

Proposal 1. The shareholders elected the 11 nominees listed below to the Company's Board of Directors, each to serve until the 2027 Annual Meeting of Shareholders and until their successor is duly elected and qualified or until their earlier resignation, removal from office or death, and voted as follows:
NomineeForAgainstAbstainedBroker Non-Votes
Robert W. Azelby176,584,8006,334,088316,84420,597,138
Michelle M. Brennan179,475,4023,292,026468,30420,597,138
Sheri H. Edison181,946,300820,461468,97120,597,138
David C. Evans181,613,6981,305,091316,94320,597,138
Patricia A. Hemingway Hall178,340,0554,303,817591,86020,597,138
Jason M. Hollar181,590,9701,395,074249,68820,597,138
Akhil Johri181,853,820899,668482,24420,597,138
Nancy Killefer180,412,5472,499,311323,87420,597,138
Christine A. Mundkur182,470,070447,558318,10420,597,138
Robert W. Musslewhite182,173,842741,729320,16120,597,138
Sudhakar Ramakrishna182,232,287676,477326,96820,597,138

Proposal 2. The shareholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers ("say-on-pay" vote), and voted as follows:
ForAgainstAbstainedBroker Non-Votes
173,487,6658,501,8861,246,18120,597,138

Proposal 3. The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent auditor for the fiscal year ending June 30, 2027, and voted as follows:
ForAgainstAbstainedBroker Non-Votes
189,914,60313,635,497282,7700
2


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Cardinal Health, Inc.
(Registrant)
Date: November 16, 2026By:/s/ Jessica L. Mayer
Name: Jessica L. Mayer
Title: Chief Legal and Compliance Officer

3

Filing Exhibits & Attachments

3 documents

Keep reading